Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction
Drug repurposing studies played an important role for fighting with the Covid-19 pandemic. Discovering a new drug molecule for a disease takes a very long time. However, repurposing a drug molecule developed for another disease can accelerate to find new treatments for a disease. Thus, several drug...
Main Author: | Sefer BADAY |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkish Chemical Society
2021-08-01
|
Series: | Journal of the Turkish Chemical Society, Section A: Chemistry |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/pub/jotcsa/issue/62350/923455 |
Similar Items
-
Antiviral Potential of <i>Antillogorgia americana</i> and <i>elisabethae</i> Natural Products against nsp16–nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation
by: Omkar Pokharkar, et al.
Published: (2023-07-01) -
Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit
by: Vladimira Horova, et al.
Published: (2021-07-01) -
Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2
by: Alessandra M. Balieiro, et al.
Published: (2022-11-01) -
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
by: Raitis Bobrovs, et al.
Published: (2021-11-01) -
Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2
by: Abdulelah Aljuaid, et al.
Published: (2022-11-01)